CHICAGO & BERKELEY, Calif. — — Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standar…
CHICAGO & BERKELEY, Calif. — — Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standar…
ASBESTOS disease victims whose condition worsens after they receive compensation could be eligible for further damages, under a proposal by the Barnett Government.
ASBESTOS disease victims whose condition worsens after they receive compensation could be eligible for further damages, under a proposal by the Barnett Government.Source: www.topix.com Via newsmixx: home News
New research shows that people who were exposed to toxic asbestos fibers do not outlive their risk of developing deadly mesothelioma.
The wife of an illustrator who died froom asbestos-related cancer has appealed for his former colleagues to come forward with information about his working conditions.
The wife of an illustrator who died froom asbestos-related cancer has appealed for his former colleagues to come forward with information about his working conditions.Source: www.topix.com Via newsmixx: home News
VA Secretary Shinseki Apologizes for Wait-List Scandal, Resigns
VA Secretary Shinseki Apologizes for Wait-List Scandal, ResignsSource: www.mesothelioma.com Via newsmixx: home News
All claims against GST will be paid in cash and in full; equal treatment of similar current and future claims is assured )–Garlock Sealing Technologies LLC , a subsidiary of EnPro Industries, Inc. , today will file an amended plan of reorganization th…
All claims against GST will be paid in cash and in full; equal treatment of similar current and future claims is assured )–Garlock Sealing Technologies LLC , a subsidiary of EnPro Industries, Inc. , today will file an amended plan of reorganization th…
Under the agreement, facilitated by the Johnson & Johnson Innovation center in in upfront license fees and milestone payments upon achievement of defined development, regulatory and commercialization milestones, if multiple programs advance to comm…
Under the agreement, facilitated by the Johnson & Johnson Innovation center in in upfront license fees and milestone payments upon achievement of defined development, regulatory and commercialization milestones, if multiple programs advance to comm…
Scientists Publish Paper Declaring Merlin Deficiency as Predictor of Cancer Drugs’ Efficacy
Scientists Publish Paper Declaring Merlin Deficiency as Predictor of Cancer Drugs’ EfficacySource: www.mesothelioma.com Via newsmixx: home News